14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
PASW vs OPTO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Ping An Biomedical Co., Ltd. (PASW) is the stronger overall head-to-head candidate over OPTO (OPTO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PASW carries a Unified Composite Score of 59.1/100 (HOLD) at $1.13 (N/M Forward P/E, -41.3% operating margin), whereas OPTO carries 47.3/100 (HOLD) at $12.11 (N/M Forward P/E, N/A operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PASW vs OPTO. Trailing 12-month operating profitability (PASW -41.3% vs OPTO N/A) and valuation multiples (PASW N/M vs OPTO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ PASW vs OPTO Key Questions & Quantitative Answers
As of Nov 20, 2026, Ping An Biomedical Co., Ltd. (PASW) is the stronger overall head-to-head candidate over OPTO (OPTO) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). PASW carries a Unified Composite Score of 59.1/100 (HOLD) at $1.13 (N/M Forward P/E, -41.3% operating margin), whereas OPTO carries 47.3/100 (HOLD) at $12.11 (N/M Forward P/E, N/A operating margin). Technically, PASW sits in a Neutral phase (RSI 41.8, UNCLASSIFIED options structure) and OPTO sits in a Neutral phase (RSI N/A, UNCLASSIFIED options structure).
PASW leads the Growth & Scale pillar: PASW posts -47.4% YoY revenue growth and +0.0% YoY earnings growth on $26M TTM revenue (9.3% gross margin, -41.3% operating margin), compared with OPTO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, PASW generates $26M in USD-normalized revenue versus N/A for OPTO. In operating R&D and SG&A reinvestment, PASW deploys 50.6% of Rev ($13M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for OPTO.
PASW screens cheaper on headline valuation multiples. PASW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-41.3% EBITDA margin), whereas OPTO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PASW (-11.3% ROE) versus OPTO (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, PASW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-10.07β · 11691% Vol realized risk). By comparison, OPTO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (3.64β · 108% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.